Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$9,606,235
+$1,851,655 QoQ
Shares Held
8,009
-5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.82%
of 13F equity value
Holder Rank
#1,282
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbia Asset Management holds $59,491,013 across 10 Drug Manufacturers - General names. LLY ranks #3 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
110,475 | $14,196,037 | |
| 2 | JNJ |
Johnson & Johnson
|
51,192 | $13,001,232 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
8,009 | $9,606,235 | |
| 4 | ABBV |
AbbVie Inc.
|
34,525 | $8,687,871 | |
| 5 | AMGN |
Amgen Inc
|
21,458 | $7,770,370 | |
| 6 | PFE |
Pfizer Inc
|
190,168 | $4,579,245 | |
| 7 | AZN |
Astrazeneca PLC
|
3,589 | $680,546 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,985 | $377,124 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,606,235 | 8,009 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $7,754,580 | 8,431 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,969,280 | 8,346 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $6,099,422 | 7,994 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $5,976,656 | 7,667 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $6,383,458 | 7,729 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $6,231,584 | 8,072 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,406,684 | 9,489 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $8,635,514 | 9,538 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $5,284 | 9,065 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,275,426 | 9,050 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,728,355 | 8,803 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,647,726 | 7,778 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,507,270 | 4,389 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,605,671 | 4,389 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,419,183 | 4,389 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,390,622 | 4,289 | Shares | Sole | 2022-08-26 | |
| 2021-12-31 | $1,184,707 | 4,289 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $990,973 | 4,289 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $984,411 | 4,289 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $879,922 | 4,710 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $795,236 | 4,710 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $697,174 | 4,710 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $785,601 | 4,785 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $661,000 | 4,765 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||